RetroSense Therapeutics Company
RetroSense Therapeutics is a biotechnology company developing gene therapy for vision restoration.
Investors
Founded Date:
2009
Total Funding:
$106M
Funding Status:
M&A
Technology:
Neurological Disorders
Last Funding Type:
Venture - Series Unknown
Investors Number:
12
Industry:
Gene Therapy
Headquarters:
Ann Arbor, Michigan, United States
Estimated Revenue:
Less than $1M